| Autor: |
Bhadran A; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Polara H; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Calubaquib EL; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Wang H; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Babanyinah GK; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Shah T; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Anderson PA; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Saleh M; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Biewer MC; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States., Stefan MC; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas 75080, United States. |
| Abstrakt: |
Thermoresponsive amphiphilic poly(ε-caprolactone)s (PCL)s are excellent candidates for drug delivery due to their biodegradability, biocompatibility, and controlled release. However, the thermoresponsivity of modified PCL can often lead to premature drug release because their lower critical solution temperature (LCST) is close to physiological temperature conditions. To address this issue, we developed a novel approach that involves functionalizing redox-responsive lipoic acid to the hydrophobic block of PCL. Lipoic acid has disulfide bonds that undergo reversible cross-linking after encapsulating the drug. Herein, we synthesized an ether-linked propargyl-substituted PCL as the hydrophobic block of an amphiphilic copolymer along with unsubstituted PCL. The propargyl group was used to attach lipoic acid through a postpolymerization modification reaction. The hydrophilic block is composed of an ether-linked, thermoresponsive tri(ethylene glycol)-substituted PCL. Anticancer drug doxorubicin (DOX) was encapsulated within the core of the micelles and induced cross-linking in the presence of a reducing agent, dithiothreitol. The developed micelles are thermodynamically stable and demonstrated thermoresponsivity with an LCST value of 37.5 °C but shifted to 40.5 °C after cross-linking. The stability and release of both uncross-linked (LA-PCL) and cross-linked (CLA-PCL) micelles were studied at physiological temperatures. The results indicated that CLA-PCL was stable, and only 35% release was observed after 46 h at 37 °C while LA-PCL released more than 70% drug at the same condition. Furthermore, CLA-PCL was able to release a higher amount of DOX in the presence of glutathione and above the LCST condition (42 °C). Cytotoxicity experiments revealed that CLA-PCL micelles are more toxic toward MDA-MB-231 breast cancer cells at 42 °C than at 37 °C, which supported the thermoresponsive release of the drug. These results indicate that the use of reversible cross-linking is a great approach toward synthesizing stable thermoresponsive micelles with reduced premature drug leakage. |
